✎ Add Post
All-oral, direct-acting antivirals have significantly improved the efficacy and safety of chronic hepatitis C treatment but their effectiveness and safety among patients with chronic kidney disease remains poorly understood.
Single-topic, short form emails with the latest articles, advocacy news, clinical slide decks, videos, meeting/conference information and more.
RISING HEALTH PREMIUMS RANKLE INDIVIDUALS PAYING FULL PRICE
Congratulations to the SSPPS Pharmacy Students for the wonderful presentations of their Summer Research works:
Read article here:
Tuesday, October 18th
Hepatitis C Treatment Challenges - A Tale of Two Epidemics
The Centers for Medicare & Medicaid Services (CMS) has determined that the evidence is sufficient to conclude that screening for Hepatitis B Virus (HBV) infection, consistent with the grade A...